NasdaqGS - Nasdaq Real Time Price
USD
Revolution Medicines, Inc. (RVMD)
191.31
+1.04
(+0.55%)
At close: October 30 at 4:00:00 PM EDT
191.25
-0.06
(-0.03%)
After hours: October 30 at 7:33:28 PM EDT
Trade RVMD on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreLoading chart for RVMD
What's happening with RVMD?
Powered by Yahoo ScoutRevolution Medicines is building on the August 2026 FDA approval of RASONQUE (daraxonrasib)for previously treated metastatic pancreatic cancer. New subgroup data support the drug’s survival benefit, while valuation, commercialization, and pipeline execution remain central investor questions.
Powered by Yahoo Scout
- Previous Close
190.27 - Open
188.38 - Bid 173.47 x 200
- Ask 204.94 x 200
- Day's Range
187.28 - 192.60 - 52 Week Range
56.66 - 224.31 - Volume
1,099,311 - Avg. Volume
1,935,231 - Market Cap (intraday)
41.005B - Beta (5Y Monthly) 1.40
- PE Ratio (TTM)
-- - EPS (TTM)
-8.87 - Earnings Date Nov 4, 2026
- Forward Dividend & Yield -- (0.00%)
- 1y Target Est
258.84 - Zacks Rating Neutral
Recent News
View More
Performance Overview
Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
RVMD
140.19%
S&P 500 (^GSPC)
10.73%
1-Year Return
RVMD
224.97%
S&P 500 (^GSPC)
11.11%
3-Year Return
RVMD
942.56%
S&P 500 (^GSPC)
81.91%
5-Year Return
RVMD
550.05%
S&P 500 (^GSPC)
64.59%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
As of 10/29/2026
-
Market Cap
40.81B
-
Enterprise Value
37.51B
-
Trailing P/E
--
-
Forward P/E
--
-
PEG Ratio (current)
--
-
Price/Sales (ttm)
--
-
Price/Book (mrq)
15.65
-
Enterprise Value/Revenue
--
-
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-30.12%
-
Return on Equity (ttm)
-79.09%
-
Revenue (ttm)
--
-
Net Income Avi to Common (ttm)
-1.77B
-
Diluted EPS (ttm)
-8.87
Balance Sheet and Cash Flow
-
Total Cash (mrq)
3.94B
-
Total Debt/Equity (mrq)
45.68%
-
Levered Free Cash Flow (ttm)
-711.61M
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Mkt Cap
undefined
-
Industry
-
Company Insights
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.
